Mancillas-Quiroz, J.A.; Carrasco-Portugal, M.d.C.; Mondragón-Vásquez, K.; Huerta-Cruz, J.C.; RodrÃguez-Silverio, J.; RodrÃguez-Vera, L.; Reyes-GarcÃa, J.G.; Flores-Murrieta, F.J.; DomÃnguez-Chávez, J.G.; Rocha-González, H.I.
Development of a Novel Co-Amorphous Curcumin and L-Arginine (1:2): Structural Characterization, Biological Activity and Pharmacokinetics. Pharmaceutics 2025, 17, 11.
https://doi.org/10.3390/pharmaceutics17010011
AMA Style
Mancillas-Quiroz JA, Carrasco-Portugal MdC, Mondragón-Vásquez K, Huerta-Cruz JC, RodrÃguez-Silverio J, RodrÃguez-Vera L, Reyes-GarcÃa JG, Flores-Murrieta FJ, DomÃnguez-Chávez JG, Rocha-González HI.
Development of a Novel Co-Amorphous Curcumin and L-Arginine (1:2): Structural Characterization, Biological Activity and Pharmacokinetics. Pharmaceutics. 2025; 17(1):11.
https://doi.org/10.3390/pharmaceutics17010011
Chicago/Turabian Style
Mancillas-Quiroz, Jose Antonio, Miriam del Carmen Carrasco-Portugal, Karina Mondragón-Vásquez, Juan Carlos Huerta-Cruz, Juan RodrÃguez-Silverio, Leyanis RodrÃguez-Vera, Juan Gerardo Reyes-GarcÃa, Francisco Javier Flores-Murrieta, Jorge Guillermo DomÃnguez-Chávez, and Héctor Isaac Rocha-González.
2025. "Development of a Novel Co-Amorphous Curcumin and L-Arginine (1:2): Structural Characterization, Biological Activity and Pharmacokinetics" Pharmaceutics 17, no. 1: 11.
https://doi.org/10.3390/pharmaceutics17010011
APA Style
Mancillas-Quiroz, J. A., Carrasco-Portugal, M. d. C., Mondragón-Vásquez, K., Huerta-Cruz, J. C., RodrÃguez-Silverio, J., RodrÃguez-Vera, L., Reyes-GarcÃa, J. G., Flores-Murrieta, F. J., DomÃnguez-Chávez, J. G., & Rocha-González, H. I.
(2025). Development of a Novel Co-Amorphous Curcumin and L-Arginine (1:2): Structural Characterization, Biological Activity and Pharmacokinetics. Pharmaceutics, 17(1), 11.
https://doi.org/10.3390/pharmaceutics17010011
